Search
for
Sort by
Research 211–240 of 1000+
- Effects of vinblastine and its metabolites on nausea and alopecia associated receptors
- Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity
- Acute and Long-term Toxicity of Cyclophosphamide
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- British Cosmetic Dermatology Group
- Patient experience with later line chemotherapy in four tumor types.
- Ki-67 Levels and Their Association With Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Prospective Observational Study
- Highlights
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Prevention of erlotinib-induced folliculitis with doxycycline
- Numerical Methods for Decision-Making in Clinical Care: Where to Now?
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Scalp Cooling Methods for Chemotherapy-Induced Hair Loss: A Comprehensive Review from Traditional Practices to Modern Innovations
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Alopecia como efeito colateral dos tratamentos em uso para o Cancro do Colo do Útero: possíveis terapêuticas preventivas
- Abstract P1-09-32: A novel candidate for chemotherapy induced alopecia (CIA) through local modulation of apoptosis and inflammation
- Management of Dermatologic Toxicities
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Dermatological Drugs, Topical Agents, and Cosmetics
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Clinical observation of simultaneous continuous infusion of fluorouracil and disodium folinate combined with oxaliplatin for metastatic colorectal cancer
- Dermatological adverse events with taxane chemotherapy
- BAWANG PUTIH SEBAGAI SALAH SATU TERAPI KOMPLEMENTER PENDAMPING DALAM UPAYA PENGOBATAN KANKER PAYUDARA: LITERATUR REVIEW
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Clinical Observation of Thyroid Cancer Treated by CAF Regimen Combined with Fufangbanmao Capsule
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome